Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02865096 · ClinicalTrials.gov registry record

The Correlation of Women's Sexual Health and Marijuana Use

A clinical trial, sponsored by St. Louis University.

Completed
Registry status
373
Enrollment target

NCT02865096: Completed study, sponsored by St. Louis University.

NCT02865096 is a clinical trial that has completed, run by St. Louis University. The registered enrollment target is 373 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02865096 has completed, sponsored by St. Louis University.

COMPLETED
Registry status
373 participants
Enrollment target

Study Summary

This study is attempting to determine whether there is any effect (worsening or improvement of sexual function) after marijuana consumption. Both users and non users of marijuana will be given the opportunity to participate by completing a questionnaire.

Primary Outcome

Study participants will fill out one anonymous questionnaire and deposit the completed questionnaire themselves in a locked box.

Trial Details

FieldValue
Enrollment Target 373 participants
Start Date 2016-03-01
Est. Completion 2017-02-01
St. Louis University

107 total trials

What the finished NCT02865096 record still lists

NCT02865096 is an observational study that tracks outcomes without assigning an intervention. The registered 373 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT02865096 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02865096 about?

NCT02865096 is a clinical study titled "The Correlation of Women's Sexual Health and Marijuana Use". This study is attempting to determine whether there is any effect (worsening or improvement of sexual function) after marijuana consumption. Both users and non users of marijuana will be given the opportunity to participate by completing a questionnaire.

What is the current status of trial NCT02865096?

This trial is currently completed. The enrollment target is 373 participants. The study started on 2016-03-01. Estimated completion is 2017-02-01.

Who is sponsoring clinical trial NCT02865096?

This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07276750 · 373 participants · NA

    Coaching and Leadership in Autism Support Settings

  • NCT04801589 · 372 participants · Phase 3

    Goal-Directed Sedation in Mechanically Ventilated Infants and Children

  • NCT04879329 · 372 participants · Phase 2

    A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

  • NCT05318105 · 372 participants · NA

    Ultrafiltration Versus IV Diuretics in Worsening Heart Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02865096, the US trial registry maintained by the National Library of Medicine. NCT02865096 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.